Korean Market
EXCH
ENCell
★

ENCell Holds NDR for Domestic Institutional Investors - Aimed at Enhancing Investor Understanding and Corporate Value

 
EXCH
ENCell
★

Extension of Advanced Biopharmaceutical Supply Contract Secures Stable Revenue Base Through 2027

 
OWNR
ENCell
★

Non-registered Executive Baek Gwang-mun Disposes of All 10,000 Shares (Gift 7,000, Sale 3,000)

 
PERI
ENCell
★

Encell: EN001 CMT1A Phase 1b safety confirmed, FDA orphan drug designation, pipeline progress